Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Open-market buy Director bought 7,000 shares at $2.85 ($19,950)
  2. 4 Open-market buy President & CEO bought 6,000 shares at $2.90 ($17,400)
  3. 4 Open-market buy Director bought 15,000 shares at $2.75 ($41,247)
  4. 4 Open-market buy Director bought 15,000 shares at $2.82 ($42,267)
  5. 4 Open-market buy Director bought 5,000 shares at $3.00 ($15,003)
  6. 4/A Open-market buy 10% owner bought 85,461 shares at $3.04 ($259,468)
  7. 4 Open-market buy 10% owner bought 85,461 shares at $4.00 ($341,844)
  8. 4 Open-market buy 10% owner bought 20,411 shares at $4.00 ($81,644)
  9. 4 Exercise or conversion Director acquired 1,028 shares (option exercise)
  10. 4 Open-market buy 10% owner bought 26,408 shares at an average $3.84 ($101,518)
  11. 4 Open-market buy 10% owner bought 358,698 shares at an average $3.81 ($1,366,146)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Exercise or conversion SVP Bus. & Corp. Development acquired 2,057 shares (option exercise)

Page 13 of 19 · 370 filings